Navigation Links
Transition Therapeutics Announces Fiscal 2007 Year End Financial Results
Date:9/12/2007

tp://www.transitiontherapeutics.com.

Financial Statements to Follow:

CONSOLIDATED BALANCE SHEETS

As at June 30

(in Canadian dollars)

2007 2006

$ $

-------------------------------------------------------------------------

ASSETS

Current

Cash and cash equivalents 1,377,387 4,074,582

Short-term investments 32,990,755 10,930,855

Receivables 741,607 371,663

Investment tax credits receivable 559,405 1,176,066

Research inventory - 587,501

Prepaid expenses and deposits 519,937 469,956

Assets held for sale - 381,948

-------------------------------------------------------------------------

Total current assets 36,189,091 17,992,571

Long-term research inventory - 2,638,098

Capital assets, net 1,174,028 1,596,643

Intangible assets 26,632,609 21,900,712

-------------------------------------------------------------------------

63,995,728 44,128,024

-------------------------------------------------------------------------

-------------------------------------------------------------------------

LIABILITIES AND SHAREHOLDERS' EQUITY

Current

Accounts payable and accrued liabilities 2,866,655 3,396,013

Due to Elan Pharma International Limited 697,743 -

Current portion of long-term debt - 29
'/>"/>

SOURCE Transition Therapeutics Inc.
Copyright©2007 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19

Related medicine news :

1. Mans Transition from Foragers to Agriculturalist Led to Increase in Birth Rates
2. Rocky Transition to the Medicare Drug Program
3. Customized Post Operation Care Offers Patients a Smooth Transition to Patients into the Community
4. Mental Health - NHS Trust Commences Specialist Transition Service
5. Permanent Weight Loss Requires Transition to Healthy Eating
6. VBI Provides Potential Targets to Diabetes Therapeutics
7. CELL THERAPEUTICS PAYS Heavily to Resolve Dispute FOR ALLEGED ILLEGAL MARKETING OF CANCER DRUG
8. PM announces a new health care order for India
9. Ramdoss Announces Introduction of RCH-II
10. Britain Announces Third Transfusion Related Mad Cow Case
11. Gates Foundation Announces $287 Million In Grants Towards AIDS Vaccine
Post Your Comments:
*Name:
*Comment:
*Email:
Breaking Medicine Technology:FDA Grants Cequent IND - Clears Way for First-Ever Clinical Trial of Orally Delivered RNAi Therapeutic: CEQ508, a tkRNAi Drug Candidate in Oncology 2FDA Grants Cequent IND - Clears Way for First-Ever Clinical Trial of Orally Delivered RNAi Therapeutic: CEQ508, a tkRNAi Drug Candidate in Oncology 3FDA Grants Cequent IND - Clears Way for First-Ever Clinical Trial of Orally Delivered RNAi Therapeutic: CEQ508, a tkRNAi Drug Candidate in Oncology 4New Analytical Training Lab Standardizes on Waters Innovative Technologies to Achieve Educational Goals 2New Analytical Training Lab Standardizes on Waters Innovative Technologies to Achieve Educational Goals 3New Analytical Training Lab Standardizes on Waters Innovative Technologies to Achieve Educational Goals 4Cambridge Scientists Archive 500,000th Crystal Structure 2Marsha Fanucci Joins Ironwood Board of Directors 5725 1Marsha Fanucci Joins Ironwood Board of Directors 5725 2RB Rubber Introduces Environmentally Friendly Antimicrobial Rubber Flooring Products 14602 1RB Rubber Introduces Environmentally Friendly Antimicrobial Rubber Flooring Products 14602 2RB Rubber Introduces Environmentally Friendly Antimicrobial Rubber Flooring Products 14602 3Vestara Awarded MedAssets Supplier Contract For Automated Pharmaceutical Waste Management Solution 60133 1Vestara Awarded MedAssets Supplier Contract For Automated Pharmaceutical Waste Management Solution 60133 2